Loree Larratt - University of Alberta

基本信息

Career Trajectory

Bio

returned to edmonton in 1987 after training in toronto for internal medicine and clinical hematology and subsequent transplant and leukemia fellowship at PMH

Research Interests

Papers共 69 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Relationship of Paroxysmal Nocturnal Hemoglobinuria (PNH) Granulocyte Clone Size to Disease Burden and Risk of Major Vascular Events in Untreated Patients: Results from the International PNH Registry

David Dingli,Jaroslaw P. Maciejewski,Loree Larratt,Ronald S. Go,Britta Höchsmann,Ke Zu,Philippe Gustovic,Alexander D. Kulagin

Annals of Hematologyno. 7 (2023): 1637-1644

Cited0Views0WOSBibtex

First-line Treatment of Chronic Lymphocytic Leukemia with Ibrutinib Plus Obinutuzumab Versus Chlorambucil Plus Obinutuzumab: Final Analysis of the Randomized, Phase III Illuminate Trial

Carol Moreno,Richard Greil,Fatih Demirkan,Alessandra Tedeschi,Bertrand Anz,Loree Larratt,Martin Simkovic,Jan Novak,Vladimir Strugov,Devinder Gill,John G. Gribben,Kevin Kwei,Sandra Dai,Emily Hsu,James P. Dean,Ian W. Flinn

Haematologicano. 9 (2022): 2108-2120

Cited69Views0WOSBibtex

A Distributed International Patient Data Registry for Hairy Cell Leukemia

Leukemia & lymphoma/Leukemia and lymphoma（2022）

Cited2Views0WOSBibtex

Cost-effectiveness of Eltrombopag Vs Intravenous Immunoglobulin for the Perioperative Management of Immune Thrombocytopenia

Manraj N. Kaur,Donald M. Arnold,Nancy M. Heddle,Richard J. Cook,Cyrus Hsia,Mark Blostein,Erin Jamula,Michelle Sholzberg,Yulia Lin,Jeannine Kassis,Loree Larratt,Alan Tinmouth,Julie Carruthers,Na Li,Yang Liu,Feng Xie

Blood Advancesno. 3 (2021): 785-792

Cited13Views0WOSBibtex

Expanded Antigen-Experienced CD160+CD8+effector T Cells Exhibit Impaired Effector Functions in Chronic Lymphocytic Leukemia

Najmeh Bozorgmehr,Isobel Okoye,Olaide Oyegbami,Lai Xu,Amelie Fontaine,Nanette Cox-Kennett,Loree M. Larratt,Mark Hnatiuk,Andrei Fagarasanu,Joseph Brandwein,Anthea C. Peters,Shokrollah Elahi

Journal for ImmunoTherapy of Cancer（2021）

Cited34Views0WOSBibtex

Pretreatment with Ibrutinib Reduces Cytokine Secretion and Limits the Risk of Obinutuzumab-Induced Infusion-Related Reactions in Patients with CLL: Analysis from the Illuminate Study

Greil Richard,Tedeschi Alessandra,Moreno Carol,Anz Bertrand,Larratt Loree,Simkovic Martin,Gill Devinder,Gribben John G.,Flinn Ian W., Wang Zhengyuan,Cheung Leo W. K., Nguyen Aaron N.,Zhou Cathy,Styles Lori,Demirkan Fatih

Annals of Hematologyno. 7 (2021): 1733-1742

Cited10Views0WOSBibtex

Clinical Characteristics and Outcome of Canadian Patients Diagnosed with Atypical Hemolytic Uremic Syndrome

Anne-Laure Lapeyraque,Martin Bitzan,Imad Al-Dakkak, Mira Francis,Shih-Han S. Huang, Roger Kaprielian,Loree Larratt,Katerina Pavenski,Christine Ribic,Axel Tosikyan,Christoph Licht, David Philibert

CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE（2020）

Cited6Views0WOSBibtex

Beneficial Effects of Eculizumab Regardless of Prior Transfusions or Bone Marrow Disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry

Alexander Roeth,David J. Araten,Loree Larratt,Austin G. Kulasekararaj,Jaroslaw P. Maciejewski,Amanda Wilson,Philippe Gustovic,Yuzuru Kanakura

European Journal Of Haematology（2020）

Cited5Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn